Detalles de la búsqueda
1.
Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthracycline therapy: results from a randomized phase III study.
J Clin Oncol
; 27(27): 4522-9, 2009 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19687336
Resultados
1 -
1
de 1
1
Próxima >
>>